Target intelligence / Profile preview

Endometrial stromal and epithelial cells (None)

Target
None
Molecular classification
Other (Cellular population)
01

Overview

Endometrial stromal and epithelial cells are the primary cellular components of the endometrium, the inner lining of the uterus that undergoes cyclic changes in preparation for pregnancy. Epithelial cells form the glandular structures and the luminal surface, while stromal cells provide the structural framework and undergo a specialized differentiation process called decidualization (StatPearls, 2023). These cells are highly responsive to the ovarian steroids estrogen and progesterone, which regulate their proliferation, differentiation, and eventual shedding during menstruation (NIH, 2022). \n\nPathological conditions involving these cells include endometrial cancer, which typically arises from the epithelial component, and endometriosis, characterized by the growth of both stromal and epithelial cells outside the uterine cavity (Nature Reviews Disease Primers, 2018). Pharmacological management of these conditions often targets the hormone receptors expressed within these cells, using agents such as progestins to counteract estrogen-driven growth or GnRH analogues to suppress systemic hormone levels (Journal of Clinical Endocrinology & Metabolism, 2021). Understanding the interaction between these two cell types is crucial for developing treatments for infertility and menstrual disorders.

Other names
Endometrial liningUterine mucosaEndometrial stromaEndometrial epithelium
02

Mechanism of action

Drugs targeting these cells primarily act by modulating nuclear hormone receptors (estrogen and progesterone receptors) to regulate gene expression, or by suppressing the hypothalamic-pituitary-gonadal axis to reduce the production of endogenous steroids that drive cellular activity.

03

Biological functions

Cell proliferationCell cycleApoptosisOther (Decidualization)Other (Hormone response)Other (Embryo implantation)Other (Menstrual cycle regulation)
04

Disease associations

CancerInflammationOther (Endometriosis)Other (Infertility)Other (Adenomyosis)Other (Abnormal uterine bleeding)
05

Safety considerations

Endometrial hyperplasiaIncreased risk of venous thromboembolismBone mineral density lossVasomotor symptomsTeratogenicity
06

Interacting drugs

Medroxyprogesterone acetate

5 more in the full profile.

07

Biomarkers

Estrogen receptor alpha (ERα)Progesterone receptor (PR)Ki-67 proliferation indexCancer antigen 125 (CA-125)

Beyond the preview

Go deeper on Endometrial stromal and epithelial cells (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endometrial stromal and epithelial cells (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call